Tom Villani Featured in Biocompare Article on 3D Cell Cultures

Check out this recent Biocompare article by Lauren Tanabe, Ph.D. where Visikol Inc's CSO Tom Villani discusses 3D cell culture models and their use in the drug discovery process. 3D cell culture models are being adopted in the drug discovery space at a rapid rate due to their in vivo relevancy. Visikol is leveraging 3D cell culture models and their patented Visikol HISTO technology to offer best-in-class 3D drug discovery assays: 

  • Antibody penetration
  • Apoptosis
  • Angiogenesis
  • Cell-cell junctions and cadherins
  • Cell proliferation
  • Cell migration
  • Cell viability
  • Cholestasis
  • Drug induced liver injury

For more information go to: Services

Visikol HISTO Microtissue
  • Fibrosis
  • Immune cell invasion
  • Inflammatory Signaling
  • Mitochondrial Health + Toxicity
  • NASH
  • Neuronal Differentiation
  • Neuronal Function
  • ROS
  • Steatosis



Michael Johnson